• Profile
Close

A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis

Arthritis & Rheumatology Dec 12, 2019

Bach M, et al. - Using enzyme-linked immunosorbent assay, in serum and plasma collected from individuals in three cross-sectional RA cohorts and gender-matched healthy controls, markers of neutrophil activation (calprotectin) and cell death (NETs) were examined in order to evaluate markers of neutrophil activation and NET formation in plasma samples, examining whether they added clinical significance in enhancing the ascertainment of prognosis and monitoring in RA individuals. It was discovered that in RA, neutrophils undergo marked activation and cell death. Thus, neutrophil biomarkers could give added clinical importance in the monitoring and prognosis of RA people and may permit for early preventive treatment intervention.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay